jolt-ca| Joint Lung

Cancer Trialist’s

Coalition Newsletter for Clinical Trial Partners

September 2017

A Randomized Phase III Study of Sublobar Resection (SR) versus Stereotactic Ablative Radiotherapy (SAbR) in

High Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC)

“Stablemates Trial”

Subsite Update Active:

• Anne Arundel Medical Center

• Boston University

• Case Western

• CHUM-Notre Dame Hospital

• Henry Ford Health System

• Intermountain Medical Center

• Lifespan Oncology Clinical Research

• Mayo Clinic Rochester

• Medical College of Wisconsin

• Memorial Health University

• Meridian Health

• Ochsner Medical Center

• Ohio State University

• Ottawa

• Penn State (Mount Nittany Medical Center)

• Penrose Cancer Center

• Providence Health and Services

• SUNY

• Swedish Cancer Institute

• University of Cincinnati

• University of Colorado

• University of Iowa• University of Kentucky

• University of Louisville Physicians

• University of Maryland

• UT Southwestern Medical Center

• University of Virginia

• Wake Forest

• West Clinic/University of Tennessee

Completed contracts and IRB approval:

• Cleveland Clinic

• Karmanos Cancer Center

• KUMC

• Thomas Jefferson University

Completed contracts:

• Beaumont Hospital

• Cincinnati

• St. Vincent's–Australia

• UC San Diego

Study Co-Chair and Surgery QA ........................................ Hiran Fernando, MD | hiran.fernando@inova.org | 703.776.3563

Study Co-Chair and Radiation QA ..................................... Robert Timmerman, MD | robert.timmerman@utsw.edu | 214.645.7651

Statistician .......................................................................... Chul Ahn, PhD | chul.ahn@utsw.edu | 214.648.9418

Clinical Research Coordinator .......................................... Sarah Hardee, MS | sarah.hardee@utsw.edu | 214.648.1836

Research Manager .............................................................. Sarmistha Sen | Sarmistha.Sen@utsw.edu | 214.645.1477

Total patients on study: 62

New Site ActivationUniversity of Iowa - Dr. Bryan Allen (PI), Assistant Professor, Department of Radiation Oncology

TIPS: If anyone needs access to REDCap, new team member, or someone that wasn’t added previously, please contact Sarah Hardee (sarah.hardee@utsw.edu). Please do not contact IROC for credentialing documentation.

Our video explains how this study can help doctors understand the advantages and disadvantages of SABR vs. surgery, so they can advise their patients about the options available and which treatment is most likely to benefit them. Watch the video at https://www.joltca.org/.